UChicago Researchers Isolate Antibodies to Treat and Diagnosis COVID-19, Work to Protect Against Future Threats

University of Chicago researchers have isolated SARS-CoV-2 monoclonal antibodies, which have the potential to both treat and diagnose COVID-19. Led by Patrick Wilson, a professor of medicine at the University…

Genes Reveal Details of ‘the Crime,’ Pathway to Develop a Novel Treatment for Neurodegenerative Disease

University of Chicago researcher Christopher Gomez is developing a gene therapy to treat a rare, neurodegenerative disease – and conducting a clinical trial, backed by Pfizer and Biogen,…

The 10 Days of Polsky: Looking Back at 2020 

The past year was unlike any we've experienced before. Despite the many challenges caused by the global COVID-19 pandemic, we stayed focused on advancing our Polsky Center mission. …

Patent of the Week: A 3D Culture System for Ovarian Cancer Research

Researchers – including Ernst Lengyel, Arthur L. and Lee G. Herbst Professor of Obstetrics and Gynecology at the University of Chicago – have developed a 3D culture system that…

Patent of the Week: Precisely Delivering High Dose Radiation to Multiple Tumor Sites

University of Chicago researchers have developed an algorithm and prototype software package that successfully generates radiation beam angles for more precisely delivering treatment to multiple tumor sites. Stereotactic ablative…

Patent of the Week: A Predictive Gene Signature for Breast Cancer Therapy

Inventors, including University of Chicago researcher Edwardine Labay, have patented a seven-gene signature that can be used to assess the risk of breast cancer progression and treatment response. The…

Patent of the Week: A Low Dose, Multi-Drug Cocktail for Breast Cancer Treatment

More than 150,000 breast cancer survivors were living with metastatic disease, three-fourths of whom were originally diagnosed with stage I-III, as of January 1, 2019, according to the American…

Patent of the Week: Identifying High-Risk Triple Negative Breast Cancer Patients

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer and has the least favorable prognosis, as there are fewer targeted medicines available. Accounting for about…

Patent of the Week: A More Functional Freeze-Dried Formulation

Lactic acid bacteria has uses in the food and feed industries, as well as in medicine and chemistry applications. The bacteria is used as a source of probiotics and…

Patent of the Week: A Low-Cost and Non-Toxic Process for Creating Sustainable Material

Thin fibers made from wood, cellulose nanofibers are apt for use in materials applications because of their desirable chemical, mechanical, and environmental properties. However, isolating these materials is a…

Patent of the Week: Improving Post-CPR Outcomes in Heart Attack Patients

Cardiogenic shock occurs when the heart has been damaged and is unable to pump enough blood. It is a common cause of death, usually brought on by a severe…

Patent of the Week: A Universal Microfluidic Culture System

Microfluidic chips are useful in several applications, such as drug discovery, because of their ability to automatically replicate various cellular environments. As opposed to traditional dish-and-pipette techniques – which…